Non-alcoholic fatty liver disease

Claudia Della Corte, Daniela Liccardo, Antonella Mosca, Andrea Vania, Valerio Nobili

Research output: Contribution to journalArticlepeer-review


Non-alcoholic fatty liver disease is rapidly becoming one of most common liver diseases in the paediatric population in industrialized countries due to the growing prevalence of obesity and overweight. Paediatric NAFLD is typically of primary origin and it is strongly associated with several features of the metabolic syndrome. The mainstay of NAFLD therapy is represented by lifestyle interventions on obesogenic environment and sedentary lifestyle, which aim to improve obesity, hepatic changes and quality of life as well. Unfortunately, this goal is very difficult to be achieved and pharmacological approaches have become necessary. Although in fairly recent years, many pharmacological agents, on the basis of pathogenetic mechanism of the disease, have been attempted, to date guidelines for the management of fatty liver are still lacking. Establishing effective therapeutic strategies to treat the disease represents the challenge for paediatric hepatologists in the near future. In this article, we briefly review the current knowledge and ideas concerning paediatric non-alcoholic fatty liver disease.

Original languageEnglish
Pages (from-to)529-534
Number of pages6
JournalPaediatrics and Child Health (United Kingdom)
Issue number12
Publication statusPublished - Dec 2013


  • Children
  • Fatty liver
  • NASH

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Non-alcoholic fatty liver disease'. Together they form a unique fingerprint.

Cite this